MEPIRAPIM

MEPIRAPIM

Systematic (IUPAC) name
(4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone
Clinical data
Legal status	CA: Schedule II
Identifiers
ChemSpider	30646772
Chemical data
Formula	C19H27N3O
Molar mass	349.9 g/mol
SMILES CCCCCN1C=C(C(N2CCN(C)CC2)=O)C3=CC=CC=C31.Cl
InChI InChI=1S/C19H27N3O.ClH/c1-3-4-7-10-22-15-17(16-8-5-6-9-18(16)22)19(23)21-13-11-20(2)12-14-21;/h5-6,8-9,15H,3-4,7,10-14H2,1-2H3;1H Key:PAIPEAYSOQABHT-UHFFFAOYSA-N

MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group^[1] and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA.^[2]

Legality

Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.^[3]

See also

• AM-2201
• JWH-073
• JWH-250
• JWH-200
• SDB-001
• List of JWH cannabinoids
• List of AM cannabinoids
• THJ-2201

References

1. "MEPIRAPIM". Cayman Chemical. Retrieved 23 June 2015.
2. Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2014). "Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products". Forensic Toxicology 32 (1): 105–115. doi:10.1007/s11419-013-0217-2.
3. "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 29 June 2015.